Ye Xiongjun

Ye Xiongjun works at Hainan Chengmei Hospital as a Chief Physician and professor with a focus on robotic and laparoscopic minimally invasive surgery for urinary tumors. His clinical scope includes diagnosis and treatment of renal cancer, urothelial cancer, and prostate cancer, with additional experience in complex urinary oncology procedures. His profile highlights renal preservation surgery for complex renal tumors, huge adrenal tumor surgery, radical prostatectomy for nerve preservation, and orthotopic bladder neoplasty. These techniques are part of an integrated treatment strategy aimed at individualized care for urinary system health.

Education

No education details are listed in the provided profile information.

Work experience

• Chief Physician — Hainan Chengmei Hospital (dates not stated).

Clinical focus and techniques

Ye Xiongjun’s urinary tumor care emphasizes minimally invasive, organ-focused surgical planning.

• Robotic and laparoscopic minimally invasive surgery for urinary tumors.
• Renal preservation surgery for complex renal tumors.
• Radical prostatectomy for nerve preservation.
• Orthotopic bladder neoplasty (bladder reconstruction).
• Huge adrenal tumor surgery.
• Integrated treatment of urinary tumors.

Professional societies and certifications

• CUA Robotics Group.
• CUDA Restoration and Reconstruction Group.
• CSCO Renal/Urothelial Carcinoma Committee.

Academic output

No publication metrics are listed in the provided profile information.

Courses and advanced training

No specific courses or advanced training details are listed in the provided profile information.

Awards and recognition

No awards are listed in the provided profile information.

For international patients considering urinary tumor surgery in Hainan, Ye Xiongjun’s profile is centered on robotic and laparoscopic approaches and nerve- and organ-preserving strategies. He provides all-round guidance and consultation for urinary system health at Hainan Chengmei Hospital. His participation in guideline writing teams and major robotics and uro-oncology committees supports consistent, evidence-oriented planning.